ALS CYTOTOXIN GEEIGNETES FUSIONSPOLYPEPTID

European patent · EP1620468 · Deleted

Register entry

Publication number
EP1620468
Application number
EP04729841
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 28, 2004
Published
Feb 1, 2006
Granted
Feb 8, 2012
Deleted
Apr 28, 2024
Reason
Maximum term reached
IPC classes
C07K 19/00 (2006.01)
C07K 14/015 (2006.01)
C12N 9/12 (2006.01)
C12N 15/62 (2006.01)
C12N 5/10 (2006.01)
A01K 67/027 (2006.01)
C07K 16/00 (2006.01)
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
A61K 38/16 (2006.01)
Priority
EP 03009952 30.04.2003
PCT application
PCT/EP2004/004477 28.04.2004
PCT publication
WO2004/096858 11.11.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 28, 2024

    Maximum term reached

    Published in Swissreg on 28.04.2024

  2. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  3. Apr 18, 2012

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 18.04.2012

  4. Feb 8, 2012

    Granted

    Published in Swissreg on 08.02.2012

Parties

Holder

Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts

Im Neuenheimer Feld 280, 69120 Heidelberg, DE

Agent

Ing. Marco Zardi c/o M. ZARDI & Co. S.A.

via Pioda 6, 6900 Lugano

Inventor

NÜESCH, Jürg, P., F.

CH-4132 Muttenz

ROMMELAERE, Jean

69110 Heidelberg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.